SKIZORIL ER 12.5 (Clozapine (12.5mg))

Skizoril ER 12.5 Capsule is indicated for the management of schizophrenia, a mental health condition characterized by symptoms such as hallucinations or delusions, which can significantly impact an individual’s cognitive functioning and behavior. The administration of Skizoril ER 12.5 can be done with or without food, although it is recommended to take it consistently at the same time daily. This practice aids in achieving stable medication levels within the body. Adhere to the prescribed dosage and duration as directed by your healthcare provider; if a dose is missed, take it as soon as it is remembered, but avoid doubling doses. It is crucial to complete the entire treatment course, even if symptoms improve. Abrupt cessation of this medication is not advised without medical consultation, as it may exacerbate symptoms. Commonly reported side effects include low blood pressure, dry mouth, headaches, increased perspiration, visual disturbances, and decreased blood pressure. It is advisable to seek medical advice if these effects persist or worsen. Prior to beginning treatment, inform your physician if you have a history of elevated body temperature with muscle rigidity, abnormal facial or tongue movements, cardiovascular issues, diabetes, Parkinson’s disease, dementia, seizures, swallowing difficulties, or liver conditions. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.